Latest News

Comfort food is back in the spotlight, and that ripple effect is starting to show up in packaged foods stocks. Rising interest in budget friendly proteins, tinned fish and simple sandwich staples is reshaping where shoppers spend at the supermarket, which can influence how investors think about food producers and processors. This article looks at how that trend connects to companies in the Packaged Foods & Processed Food Products screener and what that might mean for risk and opportunity...

On 27 June 2026, Syndax Pharmaceuticals, Inc. was removed from several Russell value benchmarks, including the Russell 2000 Value, 2500 Value, 3000 Value, and 3000E Value indexes. This broad index removal can meaningfully affect how index-linked investors and benchmark-focused funds treat the stock, potentially altering liquidity and ownership patterns. Next, we'll examine how Syndax's removal from multiple Russell value benchmarks could influence its existing investment narrative and risk...

Excelerate Energy (EE) has been added to several Russell growth and small cap indices, a change that can influence how index funds and institutional investors gain exposure to the stock. See our latest analysis for Excelerate Energy. Excelerate Energy's recent index additions come after a stretch of positive momentum, with a 30 day share price return of 14.45% and a year to date share price return of 33.03%, while the 3 year total shareholder return of 89.93% points to a strong longer term...

In late June 2026, Fluor Corporation (NYSE: FLR) was added to multiple Russell growth benchmarks and the Russell 2000 Growth-Defensive Index, while Voyageur Pharmaceuticals announced it had engaged Fluor to conduct feasibility studies for an iodine project with Bayer and an integrated contrast media manufacturing facility in North America. These developments highlight Fluor’s growing visibility in key equity benchmarks and its expanding role in complex pharmaceutical supply chain...

Genworth Financial, Inc. was removed from the Russell 2000 Dynamic Index on 27 June 2026, a change that affected its status within this widely followed benchmark. This index removal can matter for investors because funds tracking the Russell 2000 Dynamic Index may adjust their holdings, potentially reshaping Genworth’s shareholder base. Next, we’ll examine how Genworth’s removal from the Russell 2000 Dynamic Index influences its investment narrative and perceived market positioning. Explore...

Nuclear energy stocks sit at the crossroads of energy security, decarbonisation goals and ongoing global investment in capital intensive infrastructure. With bond markets reacting to inflation signals, energy prices still sensitive to geopolitical routes, and several economies leaning on policy support, many investors are looking for assets tied to reliable power generation rather than just short term sentiment. This Nuclear Energy Stocks screener helps you focus on companies across uranium...

Cullen/Frost Bankers, Inc. was recently removed from the Russell 1000 Dynamic Index, a shift that typically affects how index-tracking funds allocate capital. This index removal could alter the mix of institutional holders around Cullen/Frost, potentially influencing trading liquidity and how the bank is positioned in diversified portfolios. We’ll now examine how Cullen/Frost’s removal from the Russell 1000 Dynamic Index might influence its investment narrative and longer-term outlook...

Viridian Therapeutics recently received U.S. FDA approval for Lumvoa (veligrotug-vvze) to treat thyroid eye disease across both active and chronic stages, and the company moved to launch its first commercial product immediately. This approval sets Lumvoa apart as the first therapy cleared for thyroid eye disease regardless of disease stage, potentially expanding treatment options for a broader patient population. We’ll now look at how securing first-in-class, all-stage approval for Lumvoa...

China’s latest export controls on Japanese defense-linked entities have thrown fresh attention on the country’s aerospace and defense stocks, as investors reassess which companies could face headwinds and which might see new openings. For retail investors, this is less about guessing geopolitical outcomes and more about understanding how supply chains, dual-use technologies, and export reviews feed into business risk. This article looks at 3 stocks from Japan’s Aerospace & Defense sector...

HP stock overview HP (HPQ) is drawing attention after recent share price moves, with the stock now around $22.88. Investors are weighing its mixed return profile, including a decline over the past month but a gain over the past 3 months. See our latest analysis for HP. At the current share price of $22.88, HP’s 1 month share price return of down 15.38% contrasts with a 90 day share price return of up 20.11% and a 1 year total shareholder return of down 2.89%. This suggests recent momentum has...

On 27 June 2026, Skyward Specialty Insurance Group, Inc. was added to several Russell value and small-cap benchmarks, including the Russell 2000 Value, 2500 Value, 3000 Value, 3000E Value, and Small Cap Comp Value indices, while being removed from the Russell 2000 Dynamic Index. This broad inclusion across widely tracked value indices could increase passive fund ownership and liquidity for Skyward over time. We’ll now examine how Skyward’s broad addition to Russell value indices may...

The Heathrow third runway debate has quickly turned into more than an infrastructure story; it is now a live risk and opportunity filter for airlines with meaningful exposure to the airport. With concerns over a £33b project, competing expansion plans, and open government signals on lower cost bids, the winners and losers may not be obvious at first glance. This article picks out 3 airline stocks from our screener that appear most directly exposed to the latest Heathrow news, and explains how...

Index removal puts RenaissanceRe Holdings in focus RenaissanceRe Holdings (RNR) was recently removed from the Russell 1000 Dynamic Index, an event that can prompt index-linked funds to rebalance positions and potentially influence short term trading activity in the stock. This index change gives you a fresh opportunity to reassess RenaissanceRe Holdings on its own fundamentals, including its property and casualty reinsurance mix, recent share performance, and current valuation metrics. See...

Alexandria Real Estate Equities (ARE) has been added to both the Russell 2500 Index and the Russell 2500 Value Benchmark, a change that can influence trading activity as index-tracking funds adjust their holdings. See our latest analysis for Alexandria Real Estate Equities. The index additions come on the back of a strong near term run in Alexandria Real Estate Equities, with a 1-day share price return of 3.62% and a 90-day share price return of 19.29%. This is occurring even as the 1-year...

Amerant Bancorp stock moves after recent performance Amerant Bancorp (AMTB) has drawn fresh attention after a recent upswing in its share price, with the stock closing at US$25.42 and showing gains over the past week, month and past 3 months. See our latest analysis for Amerant Bancorp. The recent 1-day share price return of 1.84% sits on top of a 30-day share price return of 11.88% and a year-to-date share price return of 28.97%. Amerant Bancorp’s 1-year total shareholder return of 43.00%...

On 27 June 2026, Stoke Therapeutics, Inc. was removed from several Russell indices, including the Russell Microcap, Russell Microcap Growth, Russell 3000E, and Russell 3000E Growth Benchmark, reflecting updated index reconstitution decisions. This broad index removal can meaningfully alter the company’s investor base and trading patterns as index-linked funds rebalance their holdings. We’ll now examine how Stoke Therapeutics’ removal from multiple Russell indices may influence its existing...

Index additions put Graham in focus for liquidity minded investors Graham (GHM) has been added to both the Russell 2000 Defensive Index and the Russell 2000 Growth-Defensive Index, an inclusion that typically brings higher visibility and potential liquidity for the stock. See our latest analysis for Graham. The index additions come after a period of strong momentum for Graham, with the share price up 61.22% over the past 90 days and a year-to-date share price return of 83.28%. The 3-year...

Earlier this month, MongoDB Inc. reported strong fiscal Q1 2027 results, raised its full-year FY2027 guidance, and highlighted ongoing momentum in its MongoDB Atlas cloud platform alongside new AI-focused capabilities and a partnership with LangChain. Beyond the headline numbers, the closer alignment between MongoDB’s core database platform and AI tooling suggests the company is positioning its data layer as critical infrastructure for emerging AI workloads. Now we’ll examine how this...

Ollie's Bargain Outlet Holdings (OLLI) has just been added to both the Russell 1000 Defensive Index and the Russell 1000 Value-Defensive Index, a shift that can influence institutional attention and passive fund demand. See our latest analysis for Ollie's Bargain Outlet Holdings. Despite the index additions, Ollie's Bargain Outlet Holdings has seen pressure on the share price, with the 30-day share price return down 11.91% and the year-to-date share price return down 35.40%. The 3-year total...

Penny stocks often carry a reputation for high risk, but the Financially Fit Penny Stocks screener aims to filter for companies trading below $5 that still show healthier balance sheets than many early stage peers. With investors watching global signals from China’s industrial recovery to persistent inflation pressures in the US and policy moves across Europe, Japan and Latin America, this combination of low entry price and financial resilience can be appealing. This article highlights 3...

Index removals put Chesapeake Utilities back on investors' radar Chesapeake Utilities (CPK) was recently removed from multiple Russell growth benchmarks, including the Russell 3000 and 2000 Growth indices. This shift can trigger index fund repositioning and fresh scrutiny of the stock. This type of index change often leads to mechanical selling or buying by funds that track those benchmarks. It can increase short term trading volumes without necessarily reflecting any change in Chesapeake...

Earlier this year, Roche and Nurix Therapeutics announced a collaboration to co-develop and co-commercialize bexobrutideg (NX-5948), an oral Bruton’s tyrosine kinase degrader for blood cancers and other potential indications, with Nurix eligible for a US$700 million upfront payment and up to US$2.30 billion in milestones. The partnership not only brings substantial non-dilutive funding to Nurix but also pairs its lead asset with Roche’s global development and commercialization capabilities...

Recent commentary on Ryder System highlighted rising earnings expectations for 2026 and 2027 and described the logistics and transportation group as attractively valued at a forward P/E of 17.8, reinforcing interest in its US-focused operations and contract-driven revenue base. An interesting angle is that analysts are pointing to the combination of earnings momentum and sector positioning as key reasons to keep Ryder System on shortlists within logistics and transportation. We will now...

CNX Resources Corporation (NYSE: CNX) was recently removed from the Russell 2000 Dynamic Index, a change that can affect how index-tracking funds hold the stock. This index exclusion may alter the mix of institutional versus active shareholders, potentially influencing how the market interprets CNX Resources’ fundamentals and liquidity. We’ll now explore how CNX Resources’ removal from the Russell 2000 Dynamic Index could reshape its investment narrative and investor expectations. The best...